Antagonistic effects of ultra-low-molecular-weight heparin on Aβ25-35-induced apoptosis in cultured rat cortical neurons

Brain Research

Volumn 1368, Issue , 2011, Pages 1-10

  Hao, Li Na ^a   Zhang, Qing Zhu ^a   Yu, Tian Gui ^b   Cheng, Yan Na ^a   Ji, Sheng Li ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG MEDICAL COLLEGE   (China)

Author keywords

amyloid peptide; 3 (4,5 dimethylthiazol 2 yl) 2,5 diphenyl tetrazolium bromide; A ; AD; Alzheimer's disease; Amyloid precursor protein; APP; Central nervous system; CNS; DMEM F12; MTT; ULMWH; Ultra low molecular weight heparin

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; AMYLOID BETA PROTEIN[25-35]; CALCIUM ION; CASPASE 3; FLUORESCEIN ISOTHIOCYANATE; FURA 2; HEPARIN DERIVATIVE; LACTATE DEHYDROGENASE; LIPOCORTIN 5; LOW MOLECULAR WEIGHT HEPARIN; PROTEIN BCL 2; ULTRA LOW MOLECULAR WEIGHT HEPARIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN CELL; CALCIUM CELL LEVEL; CELL ASSAY; CELL VIABILITY; CONTROLLED STUDY; DRUG ANTAGONISM; EMBRYO; ENZYME RELEASE; FEMALE; NERVE CELL CULTURE; NEUROTOXICITY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STAINING; WESTERN BLOTTING;

AMYLOID BETA-PEPTIDES; ANIMALS; ANTICOAGULANTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CALCIUM; CASPASE 3; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; L-LACTATE DEHYDROGENASE; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR;

RATTUS;

EID: 78651110066     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.10.064     Document Type: Article

References (44)

1. A. Awasthi Amyloid-beta causes apoptosis of neuronal cells via caspase cascade, which can be prevented by amyloid-beta-derived short peptides Exp. Neurol. 196 2005 282 289
2. L. Bergamaschini Heparin attenuates cytotoxic and inflammatory activity of Alzheimer amyloid-β in vitro Neurobiol. Aging 23 2002 531 536
3. L. Bergamaschini Peripheral treatment with Enoxaparin, a low molecular weight heparin, reduces plaques and β-amyloid accumulation in a mouse model of Alzheimer's Disease J. Neurosci. 24 2004 4181 4186
4. M.E. Clementi Alzheimer's amyloid β-peptide (1-42) induces cell death in human neuroblastoma via bax/bcl-2 ratio increase: an intriguing role for methionine 35 Biochem. Biophys. Res. Commun. 342 2006 206 213
5. P.R. Deepa, and P. Varalakshmi Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity Toxicology 217 2006 176 183
6. B. Dudas Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Aβ(25-35)-induced abnormal tau protein immunoreactivity in rat brain Neurobiol. Aging 23 2002 97 104
7. B. Dudas Low molecular weight glycosaminoglycan C3 attenuates AF64A-stimulated, low-affinity nerve growth factor receptor-immunoreactive axonal varicosities in the rat septum Brain Res. 1033 2005 34 40
8. E. Engidawork Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease Biochem. Biophys. Res. Commun. 281 2001 84 93 (Pubitemid 32924403)
9. E. Ferreiro Involvement of endoplasmic reticulum Ca2+ release through ryanodine and inositol 1, 4, 5-triphosphate receptors in the neurotoxic effects induced by the amyloid-beta peptide J. Neurosci. Res. 76 2004 872 880
10. D.B. Freir, and C.E. Herron Inhibition of L-type voltage dependent calcium channels causes impairment of long-term potentiation in the hippocampal CA1 region in vivo Brain Res. 967 2003 27 36
11. 2+ indicators with greatly improved fluorescence properties J. Biol. Chem. 260 1985 3440 3450
12. 3 receptors channel calcium into cell death Curr. Biol. 14 2004 933 935
13. E. Hertz Preparation of primary cultures of mouse cortical neurons A. Shahar, J. Vellis, A. Vernadakis, B. Haber, A dissection and tissue culture manual of the nervous system 1989 Alan, R. Liss New York
14. Y. Higami, and I. Shimokawa Apoptosis in the aging process Cell Tissue Res. 301 2000 125 132
15. L.S. Honig, and R.N. Rosenberg Apoptosis and neurologic disease Am. J. Med. 108 2000 317 330
16. J. Hoffmann Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide Circ. Res. 89 2001 709 715
17. C. Hölscher Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies Rev. Neurosci. 16 2005 181 212
18. H. Lin Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology FASEB J. 15 2001 2433 2444
19. Q. Ma Heparin Oligosaccharides as potential therapeutic agents in senile dementia Curr. Pharm. Des. 13 2007 1607 1616
20. Q. Ma Molecular and biochemical profiling of a heparin-derived oligosaccharide, C3 Thromb. Res. 105 2002 303 309
21. Q. Ma The blood-brain barrier accessibility of a heparin-derived oligosaccharides C3 Thromb. Res. 105 2002 447 453
22. 2+ homeostasis and cell death J. Neurosci. 15 1995 6239 6249
23. M.P. Mattson Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders Trends Neurosci. 23 2000 222 229
24. M.P. Mattson Amyloid β-peptide induces apoptosis-related events in synapses and dendrites Brain Res. 807 1998 167 176
25. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63
26. K. Németh, and I. Kurucz Suppression of Ca2+ influx by unfractionated heparin in non-excitable intact cells via multiple mechanisms Biochem. Pharmacol. 69 2005 929 940
27. T.M. Niers Mechanisms of heparin induced anti-cancer activity in experimental cancer models Crit. Rev. Oncol. Hematol. 61 2007 195 207
28. C.J. Pike In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity Brain Res. 53 1991 311 314
29. 2+ homeostasis Brain Res. 1143 2007 11 21
30. M. Rose Protective effect of the heparin-derived oligosaccharide C3, on AF64A-induced cholinergic lesion in rats Neurobiol. Aging 24 2003 481 490
31. M. Rose Glycosaminoglycan C3 protects against AF64A-induced cholinotoxicity in a dose-dependent and time-dependent manner Brain Res. 1015 2004 96 102
32. V. Santini A general practice trial of Ateroid 200 in 8, 776 patients with chronic senile cerebral insufficiency Mod. Probl. Pharmacopsychiatry 23 1989 95 100
33. K. Schindowski Age-related changes of apoptotic cell death in human lymphocytes Neurobiol. Aging 21 2000 661 670
34. D.J. Selkoe Alzheimer's disease: a central role for amyloid J. Neuropathol. Exp. Neurol. 53 1994 438 447
35. J.G. Sheng Progressive neuronal injury associated with amyloid plaque formation in Alzheimer disease J. Neuropathol. Exp. Neurol. 57 1998 714 717
36. L.R. Squire Mechanisms of memory Science 232 1986 1612 1619
37. N. Strazielle In vitro evidence that beta-amyloid peptide 1-40 diffuses across the blood-brain barrier and affects its permeability J. Neuropathol. Exp. Neurol. 59 2000 29 38
38. J.C. Troncoso In situ labeling of dying cortical neurons in normal aging and in Alzheimer's disease: correlations with senile plaques and disease progression J. Neuropathol. Exp. Neurol. 55 1996 1134 1142
39. C.L. Wellington, and M.R. Hayden Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches Clin. Genet. 57 2000 1 10
40. P.C. Waldmeier, and W.G. Tatton Interrupting apoptosis in neurodegenerative disease: potential for effective therapy? Drug Discov. Today 9 2004 210 218
41. M. Walzer Low molecular weight glycosaminoglycan blockade of β-amyloid induced neuropathology Eur. J. Pharmacol. 445 2002 211 220
42. B.A. Yankner Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachynin neuropeptides Science 250 1990 279 282
43. S.Z. Zhong Peoniflorin attentuates Aβ(1-42)-mediated neurotoxicity by regulating calcium homeostasis and ameliorating oxidative stress in hippocampus of rats J. Neuro. Sci. 280 2009 71 78
44. H. Zhu Inhibition of amyloidosis using low-molecular-weight heparins Mol. Med. 7 2001 517 522